期刊文献+

阿托伐他汀后处理对GK大鼠心肌缺血再灌注损伤的保护作用 被引量:5

Protective Effect of Atorvastatin Postconditioning on Myocardial Ischemia-reperfusion Injury in GK Rat
下载PDF
导出
摘要 目的探讨不同剂量阿托伐他汀后处理对GK大鼠心肌缺血再灌注损伤的作用及其机制。方法将70只GK大鼠随机分为7组(n=10只):假手术组、缺血再灌注组(I/R组)、不同剂量(0.1、0.5、1及2 mg/kg)阿托伐他汀后处理组及阿托伐他汀后处理+LY294002组。TTC染色测定心肌梗死面积,电镜观察心肌细胞超微结构变化及Western blot测定心肌组织磷酸化蛋白激酶B(p-Akt)、总Akt(t-Akt)的蛋白表达。结果阿托伐他汀后处理组心肌梗死面积低于I/R组,心肌线粒体超微结构损伤轻于I/R组,Akt磷酸化水平高于I/R组,其中1 mg/kg和2 mg/kg阿托伐他汀后处理组较显著。PI3K特异性抑制剂LY294002可消除这种作用。结论阿托伐他汀后处理对GK大鼠心肌缺血再灌注损伤有保护作用,这可能与PI3K/Akt通路的激活有关。 Aim To investigate the effects of different dosage of atorvastatin postconditioning and its mechanisms on myocardial ischemia-reperfusion injury in GK rat. Methods Seventy GK rats were randomly divided into seven groups (n = 10 each) : sham group, ischemia-reperfusion injury (I/R) group, different dosage of atorvastatin (0. 1, 0. 5, 1 and 2 mg/kg) postconditioning group, atorvastatin + LY294002. Myocardial infarct size ( IS), ultrastructural change and myocardial expression of pbosphorylated Akt/totalAkt were determined. Results Myocardial infarct size and uhrastruc- tural damages were all reduced, myocardial Akt phosphorylation was significantly increased, and Akt was significantly activa- ted in atorvastatin postconditioning group compared with I/R group. The effects were significant at 1 mg/kg and 2 mg/kg atorvastatin posteonditioning group, and were significantly attenuated by PI3K inhibitor LY294002. Conclusion Atorv- astatin postconditioning could dose-dependently alleviate myocardial ischemia-reperfusion injury in this type 2 diabetic model, which may probably be associated with the increase of the activating PI3K/Akt signaling pathway in the myocardium.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第8期709-713,共5页 Chinese Journal of Arteriosclerosis
关键词 阿托伐他汀 心肌 缺血再灌注损伤 2型糖尿病 Atorvastatin Myoeardium Ischemia-reperfusion Injury Type 2 Diabetes
  • 相关文献

参考文献19

  • 1Topoi EJ. Current status and future prospects for acute my- ocardial infarction therapy [ J ]. Circulation, 2003, 108 ( 16 Suppl 1 ) : Ⅲ6-13.
  • 2Liao JK. Secondary prevention of stroke and transient is- chemic attack: is more platelet inhibition the answer [ J ] Circulation, 2007, 115:1 615-621.
  • 3Efthymiou CA, Mocanu MM, Yellon DM. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect impli- cating multiple prosurvival signaling [ J ]. J Cardiovasc Pharmacol, 2005, 45 (3) : 247-252.
  • 4Tissier R, Waintraub X, Couvreur N, et al. Pharmacologi- cal postconditioning with the phytoestrogen genistein[ J ]. J Mol Cell Cardiol, 2007,42 (1) : 79-87.
  • 5Krolikowski JG, Weihrauch D, Bienengraeber M, et al. Role of Erkl/2, p70s6K, and eNOS in isoflurane -induced cardioprotection during early reperfusion in vivo[ J ]. Can J Anaesth, 2006, 53 (2) : 174-182.
  • 6Baxter GF, Mocanu MM, Brar BK, et al. Cardioprotective effects of transforming growth factor-betal during early reox- ygenation or reperfusion are mediated by 1M2/p44 MAPK [J]. J Cardiovasc Pharmacol, 2001, 38 (6) : 930-939.
  • 7Wolfrum S, Dendorfer A, Schutt M. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway[J]. J Car- diovasc Pharmacol, 2004, 44 (3) : 348-355.
  • 8Hawat G, Benderdour M, Rousseau G, et al. Connexin 43 mimetic peptide Gap26 confers protection to intact heart a- gainst myocardial ischemia injury [ J ]. Pflugers Arch, 2010, 460 (3) : 583-592.
  • 9蔡炜,方军,陈昭阳,林运灵,吴黎明,陈良龙.瑞舒伐他汀后处理联合缺血后处理减轻2型糖尿病大鼠心肌缺血再灌注损伤[J].中华心血管病杂志,2010,38(9):814-818. 被引量:13
  • 10Berger C, Xia F, Maurer MH, et al. Neuroprotection by pravastatin in acute ischemic stroke in rats [ J t. Brain Res Rev, 2008, 58 (1) : 48-56.

二级参考文献29

  • 1钟慈生 孙安阳.一氧化氮的生物医学[M].上海:上海医科大学出版社,1997.16.
  • 2Zhao ZQ,Corvera JS,Halkos ME,et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.Am J Physiol Heart Circ Physiol,2003,285: H579-H588.
  • 3Riess ML,Stowe DF,Warltier DC.Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside.Am J Physiol Heart Circ Physiol,2004,286: H1603-H1607.
  • 4Gu W,Pagel PS,Warltier DC,et al.Modifying cardiovascular risk in diabetes mellitus.Anesthesiology,2003,98: 774-779.
  • 5Hausenloy DJ,Wynne A,Mocanu MM,et al.The metabolic syndrome raises the threshold for cardioprotection.J Mol Cell Cardiol,2007,42: S185.
  • 6Gu W,Kehl F,Krolikowski JG,et al.Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism.Anesthesiology,2008,108:634-642.
  • 7Masiello P,Broca C,Gross R,et al.Experimental NIDDM:development of a new model in adult rats administered streptozotocin and nicotinamide.Diabetes,1998,47: 224-229.
  • 8Kuntz E,Pinget M,Damgé C.Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes.Eur J Pharmacol,2002,448(2-3): 253-261.
  • 9Nezasa K,Higaki K,Matsumura T,et al.Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin.Drug Metab Dispos,2002,30: 1158-1163.
  • 10Flameng W,Borgers M,Daenen W,et al.Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man.J Thorac Cardiovasc Surg,1980,79: 413-424.

共引文献19

同被引文献51

  • 1董振明,罗友军,康荣田,任建军.尼可地尔预先给药对心肌缺血再灌注兔心肌细胞凋亡的影响[J].中华麻醉学杂志,2005,25(10):747-750. 被引量:9
  • 2Sardar P, Udell JA, Chatterjee S, et al. Effect of intensive versus standard blood glucose control in patients with type 2 diabetes mellitus in different regions of the world: systematic review and meta-analysis of randomized controlled trials [ J ]. J Am Heart Assoc, 2015, 4(5).
  • 3Stubhs B, Vancampfort D, De Herr M, et al. The prevalence and predictors of type two diabetes mellitas in people with schizophrenia: a systematic review and comparative meta-analysis [J]. Acta Psychiatr Scand, 2015.
  • 4Song H, Wu F, Zhang Y, et al. Irisiu promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis [J]. PLoS One, 2014, 9(10): e110273.
  • 5Hou Q, Lei M, Hu K, et al. The effects of high glucose levels on reactive oxygen species-induced apoptosis and involved signaling in human vascular endothelial cells [ J]. Cardiovasc Toxicol, 2015, 15(2) : 140 -146.
  • 6Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species [ J]. Hypertension, 2001, 37 (6) : 1450 - 1457.
  • 7Li P, Guo X, Lei P, et al. PI3K/Akt/uncoupling protein 2 signaling pathway may be involved in cell senescence and apoptosis induced by angiotensin II in human vascular endothelial cells [J]. MolBio!Rep, 2014, 41(10): 6931 -6937.
  • 8Chen HF, Liu SJ, Chen G. Heat shock protein 27 phosphorylation in the proliferation and apoptosis of human umbilical vein endothelial cells induced by high the phosphoinositide 3kinase/Akt and glucose through signalregulated kinase 1/2 pathways [J]. Mol Med extracellular Rep, 2015,11(2): 1504 -1508.
  • 9Sheu ML, Ho FM, Yang RS, et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase- regulated eye|ooxygenase-2 pathway [ J ]. Arterioseler Thromb Vase Biol, 2005, 25 (3) : 539 - 545.
  • 10Madonna R, De Caterina R. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling [ J]. Thromb Haemost, 2009, 101 (2) : 345 - 350.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部